Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Endocrinological Investigation
|
June 17, 2011
A case of thyroiditis during natalizumab therapy for multiple sclerosis
S Oddo, A Laroni, A Uccelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 6, 2010
Association of melanoma and natalizumab therapy in the Italian MS population: a second case report
A Laroni, M Bedognetti, A Uccelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 28, 2012
Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption
A Laroni, D Brogi, V Milesi, et al.
Multiple Sclerosis and Related Disorders
|
September 18, 2018
Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report
C Lapucci, F Gualandi, M Mikulska, et al.
Journal of the Neurological Sciences
|
May 27, 2021
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?
F Tazza, C Lapucci, M Cellerino, et al.
European Journal of Neurology
|
August 18, 2020
Assessing upper limb function in multiple sclerosis using an engineered glove
L Carmisciano, A Signori, M Pardini, et al.
European Journal of Neurology
|
May 18, 2020
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab
G Boffa, C Lapucci, E Sbragia, et al.
Journal of Neurology
|
January 17, 2019
Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey
L Lavorgna, S Esposito, R Lanzillo, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
May 16, 2012
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification
A Laroni, C G Giacomazzi, L Grimaldi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 21, 2010
Three years of experience: the Italian registry and safety data update
G L Mancardi, G Tedeschi, M P Amato, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Endocrinological Investigation
|
June 17, 2011
A case of thyroiditis during natalizumab therapy for multiple sclerosis
S Oddo, A Laroni, A Uccelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
November 6, 2010
Association of melanoma and natalizumab therapy in the Italian MS population: a second case report
A Laroni, M Bedognetti, A Uccelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 28, 2012
Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption
A Laroni, D Brogi, V Milesi, et al.
Multiple Sclerosis and Related Disorders
|
September 18, 2018
Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report
C Lapucci, F Gualandi, M Mikulska, et al.
Journal of the Neurological Sciences
|
May 27, 2021
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?
F Tazza, C Lapucci, M Cellerino, et al.
European Journal of Neurology
|
August 18, 2020
Assessing upper limb function in multiple sclerosis using an engineered glove
L Carmisciano, A Signori, M Pardini, et al.
European Journal of Neurology
|
May 18, 2020
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab
G Boffa, C Lapucci, E Sbragia, et al.
Journal of Neurology
|
January 17, 2019
Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey
L Lavorgna, S Esposito, R Lanzillo, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
May 16, 2012
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification
A Laroni, C G Giacomazzi, L Grimaldi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 21, 2010
Three years of experience: the Italian registry and safety data update
G L Mancardi, G Tedeschi, M P Amato, et al.
Page
of 2